Plus Therapeutics Secures Humana Coverage for CNS Cancer Assay
The agreement extends CNSide cerebrospinal fluid test coverage to 16 million additional patients nationwide.
Read More
Search Results for: glioblastoma
UnitedHealthcare Covers CNS Cancer Cerebrospinal Fluid Assay
The laboratory-developed test is used to detect and monitor metastatic central nervous system cancer.
Read More
CLIA Accreditation Clears Path for CNSide Diagnostics’ CSF Assay Platform
Houston-based facility meets federal regulatory requirements for cerebrospinal fluid testing to detect central nervous system metastases.
Read More
Leptomeningeal Disease Diagnosis in Diffuse Midline Gliomas Achieved via ctDNA Detection
Researchers diagnosed leptomeningeal disease in diffuse midline gliomas by detecting H3K27M-mutant ctDNA from cerebrospinal fluid.
Read More
Researchers Develop Affordable, Rapid Blood Test for Brain Cancer
A new automated device can diagnose glioblastoma in under an hour using a novel electrokinetic biochip that detects active EGFRs from blood.
Read More